2021-11-16 4:14 pm
Proposal for Joint Research & Development of Uterine Sarcoma Therapeutics
We are seeking collaborative partners for the non-clinical and clinical development of uterine sarcoma drugs that are inhibitors of cell cycle-related genes CDK1, CDK2, CHEK1, CHEK2, Aurora Kinase B, PLK1, or TTK (Mps1).